Pulmonary Hypertension Machine Learning-Based Notification Software
FDA product code SAT · Class II (moderate risk) · 21 CFR 870.2380 · Cardiovascular
Pulmonary hypertension machine learning-based notification software employs machine learning techniques to suggest the likelihood of pulmonary hypertension for further referral or diagnostic follow-up.
3510(k) clearances
0PMA approvals
0recalls